Promoter Vanita Nagda sold 10.43 lakh shares of Shaily Engineering Plastics through two bulk deals on June 18. According to The Financial Express, the shares were sold at ₹2,635.05 and ₹2,646.51 per share respectively, with 4 lakh shares sold on BSE and 6.43 lakh shares on NSE. The total transaction valued at approximately ₹105.4 crore was executed amid heavy trading activity, with details of the buyer not immediately available.
Shares of Shaily Engineering Plastics have experienced significant volatility, falling 7.8% in the last five trading days as reported by The Financial Express. However, the stock has delivered 3.3% returns in the last month and an impressive 15% gain in the past six months. Over the previous 12 months, the stock has raised investors' wealth by more than 58%. The heavy trading activity reflects investor reaction to the promoter stake sale, with the stock closing at ₹2,725 on June 18, declining by ₹158.30 or 5.49% from the previous close.
According to The Financial Express, Shaily Engineering Plastics reported robust Q4FY26 results with consolidated net profit surging 40.5% year-on-year to ₹40.2 crore. Revenue improved by 9% YoY to ₹237 crore in Q4FY26. For the full fiscal year FY26, the company's consolidated net profit surged by 83% year-over-year to ₹169.9 crore, compared with ₹93.1 crore in the previous year. Revenue from operations increased by 26% YoY to ₹990.7 crore, up from ₹786.8 crore in FY25. The company had reported strong year-on-year growth in Q4 FY26, with consolidated revenue rising 10.3% and net profit increasing 40.5% compared to the corresponding period last year.
Shaily Engineering Plastics is India's largest exporter of plastic components and is headquartered in Gujarat. As reported by The Financial Express, the company specialises in high-precision injection moulding and manufacturing for global Fortune 100 brands in the healthcare, personal care, consumer goods, and automotive industries. The company operates 7 manufacturing facilities in Gujarat, housing over 200 injection moulding machines and ISO Class 8 clean rooms for medical device production. Earlier this year, the company secured a manufacturing and commercial supply agreement worth around ₹423 crore from a large domestic pharmaceutical company for the supply of pen injectors over a four-year period.
